http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2012517466-A
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2095 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2013 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-145 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0019 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-44 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-06 |
| filingDate | 2009-02-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2012-08-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-2012517466-A |
| titleOfInvention | Composition comprising a biodegradable carrier for controlled drug delivery |
| abstract | The present invention relates to a controlled release pharmaceutical composition comprising a powder composition which is a binder; and a pharmaceutically active ingredient. In a first embodiment, the powder composition comprises at least a first phase calcium carbonate and a second different phase calcium carbonate, wherein the first and second phases comprise amorphous calcium carbonate; vaterite; aragonite; In a second embodiment, selected from calcite, the powder composition comprises calcium carbonate or calcium sulfate or calcium phosphate or a combination thereof. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2016507542-A |
| priorityDate | 2009-02-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 89.